Dual intracellular targeting by ruxolitinib and the Mcl-1 inhibitor S63845 in interleukin-6-dependent myeloma cells blocks in vivo tumor growth

Detalles Bibliográficos
Autores principales: Burger, Renate, Otte, Anna, Brdon, Jan, Peipp, Matthias, Gramatzki, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409037/
https://www.ncbi.nlm.nih.gov/pubmed/33882638
http://dx.doi.org/10.3324/haematol.2020.276865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409037/
https://www.ncbi.nlm.nih.gov/pubmed/33882638
http://dx.doi.org/10.3324/haematol.2020.276865

Ejemplares similares